117 related articles for article (PubMed ID: 7698209)
1. Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes.
Dumont M; Lemaire S
Eur J Pharmacol; 1994 Dec; 271(1):241-4. PubMed ID: 7698209
[TBL] [Abstract][Full Text] [Related]
2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
3. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
Shukla VK; Prasad JA; Lemaire S
J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
[TBL] [Abstract][Full Text] [Related]
4. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulation of [3H]CGP 39653 binding by glycine in rat brain.
Mugnaini M; Giberti A; Ratti E; van Amsterdam FT
J Neurochem; 1993 Oct; 61(4):1492-7. PubMed ID: 8104234
[TBL] [Abstract][Full Text] [Related]
6. A partial agonist model used in the allosteric modulation of the NMDA receptor.
Robichon R; Randall PK; Leslie SW
Eur J Pharmacol; 1997 Jun; 328(2-3):255-63. PubMed ID: 9218709
[TBL] [Abstract][Full Text] [Related]
7. Further evidence for multiple forms of an N-methyl-D-aspartate recognition domain in rat brain using membrane binding techniques.
Zuo P; Ogita K; Suzuki T; Han D; Yoneda Y
J Neurochem; 1993 Nov; 61(5):1865-73. PubMed ID: 7901335
[TBL] [Abstract][Full Text] [Related]
8. Interaction of histogranin and related peptides with [3H]dextromethorphan binding sites in rat brain.
Dumont M; Prasad J; Lemaire S
Neurosci Lett; 1994 May; 173(1-2):135-8. PubMed ID: 7936399
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations.
Zhang L; Peoples RW; Oz M; Harvey-White J; Weight FF; Brauneis U
J Neurophysiol; 1997 Aug; 78(2):582-90. PubMed ID: 9307096
[TBL] [Abstract][Full Text] [Related]
10. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
[TBL] [Abstract][Full Text] [Related]
11. Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.
Dumont M; Lemaire S
J Mol Cell Cardiol; 1993 Aug; 25(8):983-91. PubMed ID: 7903402
[TBL] [Abstract][Full Text] [Related]
12. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
13. Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.
Oblin A; Schoemaker H
Eur J Pharmacol; 1994 Jan; 266(1):103-6. PubMed ID: 7907987
[TBL] [Abstract][Full Text] [Related]
14. Modulation of a competitive N-methyl-D-aspartate receptor antagonist binding by zinc oxide.
Terse PS; Komiskey HL
Brain Res; 1997 Jan; 744(2):347-50. PubMed ID: 9027396
[TBL] [Abstract][Full Text] [Related]
15. Cloning of a brain N-methyl-D-aspartate- and D, L-epsilon-2-amino-4-propyl-5-phosphono-3-pentanoic acid (CGP 39653)-binding protein.
Kumar KN; Johnson PS; Chen X; Pal R; Ahmad M; Ragland T; Bigge C; Michaelis EK
Biochem Biophys Res Commun; 1998 Dec; 253(2):463-9. PubMed ID: 9878559
[TBL] [Abstract][Full Text] [Related]
16. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
[TBL] [Abstract][Full Text] [Related]
17. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptor antagonist activity and phencyclidine-like behavioral effects of the pentadecapeptide, [Ser1]histogranin.
Shukla VK; Lemaire S; Dumont M; Merali Z
Pharmacol Biochem Behav; 1995 Jan; 50(1):49-54. PubMed ID: 7700954
[TBL] [Abstract][Full Text] [Related]
19. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
Laurie DJ; Seeburg PH
Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
Leslie SW; Brown LM; Trent RD; Lee YH; Morris JL; Jones TW; Randall PK; Lau SS; Monks TJ
Mol Pharmacol; 1992 Feb; 41(2):308-14. PubMed ID: 1347146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
